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IN recent years much work has been done on the catalase depressing action of
fractions derived from tumour tissues. However the effects on liver catalase
produced by these fractions, or by the injection of whole homogenates of tumour
tissues, have seldom been compared quantitatively with those observed in the
tumour-bearinganimal. In fact there now seems considerabledoubtwhetherinjec-
tions oftumourhomogenates or fractions arecapable ofquantitatively simulating the action ofthe tumour on its host. In thetumour-bearing mouse mostinvestiga-
tors seem to agree that catalase activity fallsprogressivelyduring tumourgrowth, and remains low until the death ofthe animal. Recently, however, Kampschmidt,
M. E. Adams and McCoy (1959) found that when daily injections of tumour
fractions were given to mice, their catalase activity fell sharply, but after a few
days rose again while the injections were still being given. Adams (1951) injected
mice daily with homogenates of Sarcoma 37 for 4 days without observing any
restoration of the lowered catalase level. It may be, however, that the injections
were notcarried onfor asufficientlylongperiod. AdamsandRoe(I953) found that
repeateddailyinjections ofmethyl butteryellowproduced adepression in catalase
activity, followed by a return of the activity to normal by the 7th day.
It also seems that injected tumour homogenates and fractions do not depress
catalase activity to the low levels found with tumour bearing animals. However
an accurate assessment of the situation is made difficult by the use ofexcessively large tumours by some investigators, and also by the fact (Adams and Burgess,
1957) that the catalase activity measured may be principally that of the extra-
particulate cytoplasm (EPC), or that of the EPC + granules, depending on the
technique employed for the reparation of the liver tissue. In this laboratory the
following observations relating to mice bearing Sarcoma 37 have been made.
There is arapid decrease in catalaseactivity in EPC andgranule fractions until the
tumours have reached 5-10 per cent of body weight. Subsequently the decrease
continues but at a slower rate. In hosts bearing tumours of about 10 per cent of
body weight the total (EPC + granule) catalase activity is about 50 per cent of
normal. The EPC catalaseactivity is about 20 per cent ofnormal, and consequent- ly the granule/EPC catalase distribution ratio increases to about 8 in females and
6-5 in males. (Normal values with the homogenising medium used are about 5 in
females and 3-3-5 in males). It is ofinterest in this connection that Thomson and
Klipfel (1958) found thatalthough total catalase activity fellmarkedly in tumour-387 TUMOUR HOMOGENATE INJECTIONS AND CATALASE ACTIVITY
bearing animals, the distribution ofliver catalase within the intracellulargranules
did not alter. However, these authors did notstudy the distribution ofthe enzyme
between granules and EPC.
Singleinjections ofSarcoma 37homogenate were found to decrease the catalase
level in both granule and EPC fractions, and to increase the granule/EPC distri-
bution ratio, but in both males and females these changes were not so pronounced
as in tumour-bearing animals (Adams, 1959).
The purpose of the present paper is to show whether a closer simulation ofthe
tumour-bearing animal can be obtained with multiple injections of tumour homo-
genates.
MATERIALS AND METHODS
Animal8.-Young adult mice of the CBA strain were used. The animals were
bred in this laboratory by brother-sister mating. They were fed on rat cubes
obtained commercially.
Preparation of liverfractions and estimations of liver catalase activity.-Catalase
estimations were made on whole liver homogenates, and on granule and EPC
fractions. The method of estimation of catalase activity has been fully described
in previouspublications (Adams, 1950, 1952) and also thepreparation ofthe homo-
genates and fractions (Adams and Burgess, 1957, 1959a). Ethanol (final concen-
tration 0-01 m) was added to all catalase-containing solutions, to prevent loss of
catalase due to
" Complex II
" formation (Chance, 1950 ; Adams and Burgess,
1959b).
Tumour.-Sarcoma 37 was obtained originally from the Imperial Cancer
Research Fund Laboratories and maintained by serial passage in this laboratory.
Tumour (and normal) tissues were coarsely homogenised in normal saline solution
andinjectedsubcutaneously. The doses cited areweights oftissue (ashomogenate)
contained in the inoculum.
RESULTS
It was decided at first tostudy the effects ofdaily'inj'ections of a chemicalagent
on liver catalase activity and intracellular distribution of catalase. Since (Adams,
1960) animalsinjectedwiththiourea had beenfound to havelow catalaseactivities,
a comparison was made ofthe effects ofsingle and-multiple doses ofthis substance
on the catalase activity and intracellular distribution in male mice (Fig. 1). The
results show that single doses of 6limoles or IO#moles of thiourea produced a
depression of catalase activity in both granule and extra-particulate cytoplasmic
(EPC) fractions without change in the granu'le/EPC catalase distribution ratio.
By the 4th or 5th day the catalase activity had returned to normal. It is evident
from Fig. I that continuous daily injections of 6#moles of thiourea gave results
resembling those seen after the injection of the single dose of 10,umoles. Fig. 2
shows the effect ofthe continuousdailyinjection ofvarying doses ofmixed normal
liver-spleen-kidney homogenate prepared from 101 strain mice on the catalase
activityanddistributionratio ofCBAfemale mice. Adailydoseof25 mg.produced
a fall in catalase activity followed by a return to normal by the 4th day. Fifty
mg./dayproduced agreater depression, and the activitv beLyan to rise again after
three days. Some evidence of a rise in catalase activity from the lowest point was388 D. H. ADAMS
also obtained with a dose of 100 mg./day but since the mice did not tolerate this
dose well, theexperiment was not continuedbeyond the 5thday. At no time was
there anysignificant change in thegranule/EPC catalase distribution ratio.
A similar experiment was done using a homogenate of Sarcoma 37 tissue.
Daily injections of 25 mg. produced little effect on the granule catalase activity,
but significantly reduced the EPC level. Fifty mg./day produced depressions of
activity in both fractions followed by restoration of the granule catalase activity
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FIG. I.-A comparison of the effects on liver catalase activity and granule/EPC distribution
ratio of single and continuous daily injections of thiourea. Doses given at times indicated
by t
. Graph (a) 6pmoles (b) IO pmoles (e) 6pmoles/day. Total catalase (A- -'L),
granule catalase (o O) and EPC catalase (o- 0) activities are given in this and
subsequent figures as arithmetic means ± Std. error of mans. Eight animals/group.
to normal by the 5th day, but the EPC catalase remained depressed. The results
of the I00 mg./day dose showed a rise from the minimum level by the fifth day.
As with the normal tissue, this dose was not well tolerated by the mice. Unlike
the normal tissue experiments, the granule/EPC catalase distribution ratio was
increased to about 6-0-6-5, and this occurredindependently ofdose.
In a further experiment male mice were injected daily with 50 mg. doses of
homogenised S37, and another grou- with the same dose of liver-spleen-kidney
homogenate. As with the female mice the normal tissue produced a depression in
catalase activity without change in the granule/EPC distribution ratio. The rise
ofcatalaseactivityfrom the lowestpoint was morepronounced than in the females
receiving the same dosage. An increase in catalasegranule/EPC distribution ratio
was found in the males treated with S37, and there was a sharp rise in catalaseTUMOUR HOMOGENATE INJECTIONS AND CATALASE ACTIVITY 389
activityfromthe lowestpoint. Itappeared inthisexperimentthat the distribution
ratio also wasreturning towards normal on the 3rd and 4thdays.
DISCUSSION
The results have shown clearly that while multiple injections of Sarcoma 37
produced a depression in liver catalase level and an increase in catalase granule/
EPC distribution ratio the tumour injections failed in a number of respects to
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FiG. 2.-The effect ofthe continuousdailyinjection ofnormal tissue (mixedLSK) homogenate
on the catalase activity and granule/EPC distribution ratio in CBA female mice. (a) 25
mg./day (b) 50 mg./day (e) 100 mg./day.
simulate the picture in the tumour-bearing mice. Even when the dose was raised
tothe maximumtoleratedbytheanimals, Sarcoma 37homogenatefailed toincrease
the catalase granule/EPC distribution ratio beyond 6-0-6-5 in females and 4-9
in males compared with about 8-0 and 6-5 in tumour-bearing females and males.
Also the total catalase activity was still 60 per cent of normal as against about
40 per cent or less in tumour-bearing animals (Adams, 1959). The increase in
distribution ratio was independent of dose over the range studied.
The experiments with thiourea showed that the catalase activity of treated
animals was able to return to normal while the injections were stillbeinggiven.390 D. H. ADAMS
Thissuggests that the rateofcatalasesynthesis can be increasedconsiderablyto
meet extra demands on the enzyme. There must however be limits to the ability
ofthesystem to restore catalaseactivity tonormal, during the continuousinjection
of agents which reduce the activity. Thus, although in the tissue homogenate
injection experiments there was evidence that catalase activity rose from the
lowestpointduring theinjection ofdoses up to 50 mg./day, it wasnot clearwhether
550
500
450
400 z
4
E
350
C
300
250
100
90
80 -
70
60
50
40
G/EPC 50 5-2 5-7 6-2 6-1 5-0 6-2 6-1 6'5 6-2 5-8 5-0 6-0 6-3 6-1 6-1 6-1
0 2 3 4 0 1 2 3 4 5 0 2 3 4 5
Time in days
FiG. 3.-The effect of continuous daily injections of S37 tissue homogenate on the catalase
activity and granule/EPC distribution ratio in CBA female mice. (a) 25 mg./dav (b) 50
mg./day (c) 100 mg./day.
this occurred during the injection of 100 mg./day. There was, it is true some
evidence of a rise from the lowest point, but it was not possible to continue the
experimentsbeyondabout 5days. In anyevent, however, ifthe catalasedepression
intumour-bearing animals is due to release of aspecific tumour agent plus tumour
breakdown products it follows that the liberation of at least 100 mg./day of
tumour substance would be required to prevent a return of catalase activit to
normal. But it seems that not even this dose will alter catalase activity and distri-
bution ratio to the values reached in tumour-bearing animals. If catalase levels
following the continuousinjection oftumour tissue are compared with those found
in tumour-bearing animals (Adams, 1959), 100 mg./day of S37 is equivalent to the
presence in the host of a tumour weighing one gram or less. Apart from the fact391 TUMOUR HOMOGENATE INJECTIONS AND CATALASE ACTIVITY
that I00 mg. of tissue/day was the maximum dose tolerated by the animals, it
seems unreasonable to suppose that tumours are capable ofreleasing this amount
of breakdown products per day, especially in the early stages ofgrowth. Further
the loss in total catalase activity following the injectio'n of S37 homogenate is
if anything less than that following the injection of normal LSK homogenate,
leaving little or no room for the contribution of aspecific tumouragent. It may be
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FIG. 4.-The effects of the continuous daily injectionof (a) 50 mg. S37 homogenate, (b) 50 mg. normal LSK as homogenate, on the catalase activity and granule/EPC distribution ratio
of CBA male mice.
argued that the catalasedepressing effect ofthe tumour ismainly due to the release
of a specific agent, but as alreadystated,Kampschmidt, M. E. Adams andMc'Coy (I959) found that catalase activity rose to normal while tumour fractions were
being injected, so that either this agent must be absent from, or present in insuf-
ficient amount in such fractions, or some other effect of the growing tumour must
be sought for.
Onepoint of interest arising from this paper is that the EPC catalase activity ofthe CBA males was not decreased to agreater extent than that offemalesby the
injection of tumour homogenate. This contrasts with earlier results reported
using an albino strain (Adams, 1950, 1951). Recently (Adams, 1960, and unpub- lished experiments) evidence has been obtained that different androgenic hor-
mones arepresent in the CBA and albino strain ofmice. CBA female miceinjected392 D. H. ADAMS
withtestosteronehad EPC catalase levels elevated abouthalfway to the malelevel.
The EPC catalase level of females of the albino strain under the same conditions
was elevated to the male level. When 17 methyltestosterone was injected into
females of both strains, the EPC catalase activity of the CBAs rose to the male
level, and of the albinos to considerably above the male level. In view of the
evidence (Adams, 1951) that a tumouragent interferes withthe action ofhormones
on catalase, one explanation ofthe greater resistance ofthe catalase in CBA mice
may be that they secrete a different androgenic hormone.
It was suggested (Adams, 1959) that the effects on catalase produced by
tumour homogenate injections could be divided into two parts: a depression in
total catalaseactivity, whichappeared quitenon-specific, and achange in catalase
distribution. The present work lends additional support to this view, and it may
well be asked what relevance the ability of tumour homogenates or fractions to
depre88 catalaseactivity has to the lowered catalaseactivity in thetumour-bearing
animal. It is therefore proposed to continue this enquiry on the supposition that
an agent present in tumours induces changes in the host which, in conjunction
with certain nutritive demands of the tumour, lead to the observed changes in
host catalase activity and distribution.
SUMMARY
(1) The changes in mouse liver catalase activity and distribution following multipleinjections ofSarcoma 37 homogenate resemble, but do not quantitatively match, those seen in S37-bearing mice.
(2) It is concluded that a tumour agent alone canhardly be responsible for the
observed changes in tumour-bearing animals.
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